Literature DB >> 18660856

Best of the 2008 AUA Annual Meeting: Highlights from the 2008 Annual Meeting of the American Urological Association, May 17-22, 2008, Orlando, FL.

Michael K Brawer1, Danil V Makarov, Alan W Partin, Claus G Roehrborn, J Curtis Nickel, Shing-Hwa Lu, Naoki Yoshimura, Michael B Chancellor, Dean G Assimos.   

Abstract

Keywords:  Alpha-blocker therapy; Bariatric surgery; Chronic pelvic pain syndromes; Cryotherapy; Early prostate cancer antigen; Elocalcitol; Focal therapy; High-intensity focused ultrasound; Intravesical prostatic profusion parameter; Lithium triboride laser; Overactive bladder syndrome; Prostate cancer gene 3; Prostate-specific antigen; Shock wave lithotripsy; Stone formation; TMPRSS2-ERG; Tumor markers; Ultrasound-estimated bladder weight

Year:  2008        PMID： 18660856      PMCID： PMC2483319     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  20 in total

Review 1.  Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 1: Nonurodynamic approach.

Authors:  Mohammed Belal; Paul Abrams
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

2.  Natural history of residual fragments following percutaneous nephrostolithotomy.

Authors:  Jay D Raman; Aditya Bagrodia; Amit Gupta; Karim Bensalah; Jeffrey A Cadeddu; Yair Lotan; Margaret S Pearle
Journal:  J Urol       Date:  2009-01-18       Impact factor: 7.450

3.  Inhibition of prostate growth and inflammation by the vitamin D receptor agonist BXL-628 (elocalcitol).

Authors:  Luciano Adorini; Giuseppe Penna; Susana Amuchastegui; Chiara Cossetti; Francesca Aquilano; Roberto Mariani; Benedetta Fibbi; Annamaria Morelli; Milan Uskokovic; Enrico Colli; Mario Maggi
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-22       Impact factor: 4.292

Review 4.  Pre-clinical evidence and clinical translation of benign prostatic hyperplasia treatment by the vitamin D receptor agonist BXL-628 (Elocalcitol).

Authors:  M Maggi; C Crescioli; A Morelli; E Colli; L Adorini
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

5.  Correlation of intravesical prostatic protrusion with bladder outlet obstruction.

Authors:  S J Chia; C T Heng; S P Chan; K T Foo
Journal:  BJU Int       Date:  2003-03       Impact factor: 5.588

6.  Holmium laser enucleation of the prostate: efficiency gained by experience and operative technique.

Authors:  Michael W Dusing; Amy E Krambeck; Colin Terry; Brian R Matlaga; Nicole L Miller; Mitchell R Humphreys; Ehud Gnessin; James E Lingeman
Journal:  J Urol       Date:  2010-06-19       Impact factor: 7.450

7.  Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer.

Authors:  J L Chin; C-K Ng; N J Touma; N J Pus; R Hardie; M Abdelhady; G Rodrigues; J Radwan; V Venkatesan; M Moussa; D B Downey; G Bauman
Journal:  Prostate Cancer Prostatic Dis       Date:  2007-06-19       Impact factor: 5.554

8.  An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients.

Authors:  Chuan-Guo Xiao; Mao-Xin Du; Chengpu Dai; Bing Li; Victor W Nitti; William C de Groat
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

9.  Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma.

Authors:  Ghil Suk Yoon; Wenle Wang; Adeboye O Osunkoya; Zhaoli Lane; Alan W Partin; Jonathan I Epstein
Journal:  J Urol       Date:  2008-04-18       Impact factor: 7.450

10.  Botulinum toxin type A normalizes alterations in urothelial ATP and NO release induced by chronic spinal cord injury.

Authors:  Christopher P Smith; David A Gangitano; Alvaro Munoz; Nilson A Salas; Timothy B Boone; K Roger Aoki; Joseph Francis; George T Somogyi
Journal:  Neurochem Int       Date:  2007-11-26       Impact factor: 3.921
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.